If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLegal & General Regulatory News (LGEN)

Share Price Information for Legal & General (LGEN)

Share Price is delayed by 15 minutes
Get Live Data
292.10    0.70 (0.24%)
Bid:
291.90
Ask:
292.00
Spread: 0.10 (0.034%)
Market Cap: £15.99b
LGEN Live PriceLast checked at - London Stock Exchange

Intraday Legal & General Share Chart

Publication of Final Terms

1 May 2020 08:30

RNS Number : 5475L
Legal & General Group Plc
01 May 2020
 

Legal & General Group PlcPublication of Final Terms01 May 2020

LEGAL & GENERAL GROUP PLC

Publication of Final Terms

The Final Terms dated 29 April 2020 relating to the issue by Legal & General Group Plc on 1 May 2020 of £500,000,000 Fixed Rate Reset Subordinated Notes due 2050 (the "Notes") have been submitted to the Financial Conduct Authority and are available for viewing.

The Notes will be issued under the £5,000,000,000 Euro Note Programme of Legal & General Group Plc and Legal & General Finance PLC.

Application has been made for the Notes to be admitted to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange with effect from 1 May 2020.

To view the full document, please paste the following URL into the address bar of the browser:

https://www.legalandgeneralgroup.com/media/17778/final-terms-dated-29-april-2020.pdf

The Final Terms were also submitted to the National Storage Mechanism where they will be available for inspection shortly at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

For further information please contact:

Frank Turley

Group Treasurer

Legal & General Group plc

One Coleman Street

London

EC2R 5AA

Telephone: 020 3124 2060

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the prospectus dated 19 March 2020 and the supplemental prospectus dated 22 April 2020 (together, the "Base Prospectus")) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and/or the Base Prospectus, you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

The Notes offered by the Base Prospectus and the Final Terms have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), or any relevant securities laws of any state of the United States and are subject to U.S. tax law requirements. Subject to certain exceptions, the Notes may not be offered, sold or delivered in the United States, as defined in Regulation S under the Securities Act. Neither the Base Prospectus nor the Final Terms may be accessed from, or transmitted in or into, the United States.

Your right to access this service is conditional upon complying with the above requirements.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFTZBLFXBZLEBBD
Date   Source Headline
3rd Jul 20263:30 pmRNSPublication of Offering Memorandum
2nd Jul 20266:15 pmRNSDirector/PDMR Shareholding
1st Jul 20266:15 pmRNSAdmission to Trading
1st Jul 20266:15 pmRNSDirector/PDMR Shareholding
1st Jul 20266:15 pmRNSTotal Voting Rights
1st Jul 20268:12 amRNSStabilisation Notice
30th Jun 20265:00 pmRNSTender Offer - Maximum Acceptance Amount
30th Jun 20268:56 amRNSStabilisation Notice
30th Jun 20268:27 amRNSTender Offer
29th Jun 20266:15 pmRNSTransaction in Own Shares
22nd Jun 20266:15 pmRNSDirector/PDMR Shareholding
22nd Jun 20266:15 pmRNSTransaction in Own Shares
15th Jun 20266:15 pmRNSTransaction in Own Shares
9th Jun 20266:15 pmRNSDirector/PDMR Shareholding
8th Jun 20266:15 pmRNSDirector/PDMR Shareholding
8th Jun 20266:15 pmRNSTransaction in Own Shares
2nd Jun 20266:15 pmRNSDirector/PDMR Shareholding
2nd Jun 20266:15 pmRNSDirector/PDMR Shareholding
1st Jun 20266:15 pmRNSDirector/PDMR Shareholding
1st Jun 20266:15 pmRNSAdmission to Trading
1st Jun 20266:15 pmRNSTransaction in Own Shares
1st Jun 20266:15 pmRNSTotal Voting Rights
26th May 20266:15 pmRNSTransaction in Own Shares
26th May 20269:00 amRNSOutcome of Audit Tender
21st May 20264:15 pmRNSResult of AGM and GM
20th May 20266:15 pmRNSDirector/PDMR Shareholding
18th May 20266:15 pmRNSTransaction in Own Shares
11th May 20266:15 pmRNSTransaction in Own Shares
5th May 20266:15 pmRNSDirector/PDMR Shareholding
5th May 20266:15 pmRNSTransaction in Own Shares
5th May 202612:15 pmRNSHolding(s) in Company
1st May 20266:15 pmRNSDirector/PDMR Shareholding
1st May 20266:15 pmRNSTotal Voting Rights
1st May 20266:15 pmRNSAdmission to Trading
1st May 20266:15 pmRNSDirector/PDMR Shareholding
28th Apr 20266:15 pmRNSDirector/PDMR Shareholding
27th Apr 20266:15 pmRNSTransaction in Own Shares
21st Apr 20266:15 pmRNSDirector/PDMR Shareholding
20th Apr 20266:15 pmRNSTransaction in Own Shares
13th Apr 20266:15 pmRNSTransaction in Own Shares
10th Apr 20266:15 pmRNSDirector/PDMR Shareholding
10th Apr 20266:15 pmRNSDirector/PDMR Shareholding
10th Apr 20266:15 pmRNSDirector/PDMR Shareholding
10th Apr 20266:15 pmRNSDirector/PDMR Shareholding
10th Apr 20266:15 pmRNSDirector/PDMR Shareholding
9th Apr 202610:00 amRNSNotice of 2026 AGM and GM
8th Apr 20266:15 pmRNSDirector/PDMR Shareholding
8th Apr 20266:15 pmRNSDirector/PDMR Shareholding
7th Apr 20266:15 pmRNSTransaction in Own Shares
1st Apr 20266:15 pmRNSAdmission to Trading

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.